News

GlobalData on MSN8h
Debiopharm and Alkyon link for radioligand therapies development
The partnership will use Debiopharm's AbYlink conjugation tech in combination with Alkyon’s modular antibody platform.
AZoSensors on MSN9h
Nanoplasmonic Biosensors Emerge as Key Tools in Virus Detection, Drug Screening, and Immune Monitoring
Nanoplasmonic biosensors are revolutionizing virus detection, drug screening, and immune profiling, enhancing virology research with exceptional sensitivity.
Le Lézard4h
Johnson & Johnson's dual-targeting CAR T-cell therapy shows encouraging first results in large B-cell lymphoma
Johnson & Johnson announced today the first clinical data from an ongoing Phase 1b study for JNJ-90014496 (JNJ-4496), an investigational dual-targeting anti-CD19/CD20 bispecific autologous chimeric ...